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Abstract
 
Chemokine receptors transduce signals important for the function and trafficking of leukocytes.
Recently, it has been shown that CC chemokine receptor (CCR)8 is selectively expressed by
Th2 subsets, but its functional relevance is unclear. To address the biological role of CCR8, we
generated CCR8 deficient (
 
2
 
/
 
2
 
) mice. Here we report defective T helper type 2 (Th2) im-
 
mune responses in vivo in CCR8
 
2
 
/
 
2
 
 mice in models of 
 
Schistosoma mansoni
 
 soluble egg antigen
(SEA)-induced granuloma formation as well as ovalbumin (OVA)- and cockroach antigen
(CRA)-induced allergic airway inflammation. In these mice, the response to SEA, OVA, and
CRA showed impaired Th2 cytokine production that was associated with aberrant type 2 in-
 
flammation displaying a 50 to 80%
 
 
 
reduction
 
 
 
in eosinophils. In contrast, a prototypical Th1 im-
mune response, elicited by 
 
Mycobacteria bovis
 
 purified protein derivative (PPD) was unaffected
by CCR8 deficiency. Mechanistic analyses indicated that Th2 cells developed normally and
that the reduction in eosinophil recruitment was likely due to systemic reduction in interleukin
5. These results indicate an important role for CCR8 in Th2 functional responses in vivo.
Key words: chemokine receptors • chemokines • T helper type 2 cells • allergy • granulomas
 
Introduction
 
Numerous chemokines with similar structure and diverse in
vitro activities have been described but their physiologic
role remains to be fully established (1). Although the pri-
mary function of chemokines is considered to be chemotac-
tic, many studies suggest that they have complex regulatory
functions that extend beyond leukocyte trafficking (2–5).
To clarify the physiologic functions of chemokines, recent
efforts have focused on defining the cellular expression and
distribution of their G protein–coupled receptors. To date,
several of these receptors have been characterized and evi-
dence suggests differential expression by leukocyte subpop-
ulations (6, 7). In particular, lymphocyte subpopulations are
reported to display restricted expression of chemokine re-
ceptors, raising the possibility of receptor-based immune
manipulation (8). Intriguingly, this differential receptor ex-
pression includes both human and mouse type 1 (Th1) and
type 2 (Th2) Th cells. Specifically, Th1 cells are associated
 
with CXC chemokine receptor 3 (CXCR3)
 
1
 
 expression,
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whereas Th2 cells preferentially express CC chemokine re-
ceptor (CCR)3 and CCR4 (9, 10). More recently, the
CCR8 is reportedly among those preferentially expressed
on Th2 cells (11, 12). Indeed, the ligands for this receptor,
I-309 in humans and T cell activation–specific gene 3
(TCA3) in mice, are chemotactic for Th2 cells in vitro (11).
However, the in vivo function of CCR8 and its ligands is
unknown.
To assess the role of CCR8 in vivo, we examined multi-
ple immune and inflammatory parameters in mice with a
targeted deletion of the CCR8 gene. These studies re-
vealed impaired Th2 cytokine production and eosinophil
recruitment during Th2-mediated responses, with no abro-
gation of the Th1 response. Moreover, Th2 cell develop-
ment in vitro was normal, suggesting that the defect in Th2
responses was functional in nature. Taken together, these
findings suggest that CCR8 is required for optimal Th2 re-
sponses in vivo. Thus, CCR8 may provide a potential tar-
get for selective therapeutic manipulation of Th2-mediated
hypersensitivity states.
 
Materials and Methods
 
Gene Targeting.
 
A 1.2-kb BglII DNA fragment of the
mCCR8 gene containing the 5
 
9
 
 region of homology, and a 6.5-kb
BglII-HindIII fragment containing the 3
 
9 
 
region of homology
were sequentially cloned into pOS Dupdel plasmid (a gift of Dr.
O. Smithies, University of North Carolina at Chapel Hill, Chapel
Hill, NC). This targeting vector was designed so that the entire
coding sequences of the murine CCR8 gene was replaced with the
neomycin (neo) gene (see Fig. 1 A). This targeting vector was lin-
earized with NotI restriction digestion and electroporated into em-
bryonic stem (ES) cells. Neomycin-resistant ES cell clones were
screened for homologous recombination by PCR with the prim-
ers TY118 (5
 
9
 
-CACGCTGTTCCATTGCTCTGGAG-3
 
9
 
) and
TY70 (5
 
9
 
-GGGTTTGCTCGACATTGGGTGG-3
 
9
 
). A total of
five positive clones were identified. Confirmation of the recombi-
nant ES cells was done by Southern blot analysis of PstI-digested
genomic DNA hybridized to a 0.5-kb 5
 
9 
 
end probe detecting 2.5-
kb and 1.7-kb fragments corresponding to the wild-type and mu-
tant alleles, respectively (see Fig. 1, B and C).
 
Mice.
 
Four CCR8 targeted clones were injected into
C57Bl/6J blastocysts. Chimeras from these clones were mated
with C57Bl/6J females. Germline transmission of the targeted
CCR8 allele was detected in animals generated from three inde-
pendent clones. Heterozygous mice were bred and live offspring
of the expected 
 
1
 
/
 
1
 
, 
 
1
 
/
 
2
 
, and 
 
2
 
/
 
2
 
 CCR8 genotypes were
identified. Confirmation of the null phenotype was done by re-
verse transcription (RT)-PCR using RNA derived from lungs of
CCR8 
 
1
 
/
 
1
 
 and 
 
2
 
/
 
2
 
 mice (see Fig. 1 D). Mice lacking CCR8
were generated in the 129Sv and in the 129Sv 
 
3 
 
C57BL/6
backgrounds. Controls consisted of littermate CCR8
 
1
 
/
 
1
 
,
CCR8
 
1
 
/
 
2
 
 129sv mice, and CCR8
 
1
 
/
 
1 
 
129Sv 
 
3
 
 C57BL/6 F2
mice obtained from The Jackson Laboratory. CCR8
 
2
 
/
 
2
 
 mice
displayed similar defects when compared with all control strains.
 
Schistosoma mansoni
 
–infected Swiss outbred mice were obtained
from Biomedical Research Laboratories. All mice were main-
tained under specific pathogen-free conditions and provided
with food and water ad libitum.
 
Sensitization and Granuloma Induction.
 
For comparison of type
1 and 2 granulomas, secondary Ag-bead granulomas were gener-
 
ated as described previously (13). In brief, mice were sensitized
by subcutaneous injection of 20 
 
m
 
g purified protein derivative
(PPD; Department of Agriculture, Veterinary Division, Ames,
IA) of 
 
Mycobacteria bovis 
 
incorporated into 0.25 ml CFA (product
no. F-5881; Sigma-Aldrich) or 3,000 
 
S. mansoni
 
 eggs suspended
in 0.5 ml PBS. 14 to 16 d later, PPD and schistosome egg–sensi-
tized mice were respectively challenged by tail vein with 6,000
Sepharose 4B beads (in 0.5 ml PBS) covalently coupled to PPD
or to soluble schistosome egg antigens (SEA) obtained from the
World Health Organization. Study parameters were evaluated on
day 4 of granuloma formation.
 
Lung Aqueous Extracts.
 
Snap-frozen lung lobes were sus-
pended in 2 ml of PBS and homogenized for 20 s using a Tissue
Tearor (Biospec Products, Inc.). Next, 0.1 ml of fetal bovine se-
rum (FBS) was added as a protein stabilizer. The homogenate was
centrifuged at 3,000 
 
g
 
 for 20 min, and then the supernate was
collected, aliquoted, and frozen at 
 
2
 
80
 
8
 
C before cytokine assay.
Total protein concentration was determined in experimental and
control samples, then cytokine levels were normalized to milli-
grams of lung protein after subtraction of the FBS protein com-
ponent.
 
Sensitization and Induction of the Allergic Airway Response.
 
To
induce a Th2 type response, control and knockout mice were
immunized with cockroach allergen (Bayer Pharmaceuticals), as
described previously (14). At the end of the sensitization phase,
mice were then rechallenged once with allergen for cytokine
analysis. Induction of the ovalbumin allergic response was per-
formed in a similar manner as described previously (15). Cyto-
kines and chemokines were quantified in homogenized (PBS)
lung aqueous extracts and cell-free supernatants by specific ELISA.
 
Analysis of Leukocyte Subsets in Lungs of Allergic Mice.
 
Leuko-
cyte differentials and flow cytometric analyses of lymphocyte sub-
sets were carried out in dispersed lung samples from CCR8
 
1
 
/
 
1
 
and CCR8
 
2
 
/
 
2 
 
allergic mice. Mice immunized and challenged
with cockroach allergen were killed and the lungs were inflated
in situ with 1 ml ice-cold RPMI 1640, excised, and chopped into
2- to 3-mm pieces. Chopped lung tissue was resuspended in 3
volumes of sterile digestion medium consisting of RPMI 1640
containing 10 mM Hepes, 0.2% type IV collagenase, and 20 
 
m
 
g/
ml tissue culture grade gentamicin. The mixture was agitated for
45 min at 37
 
8
 
C. The resulting suspension was strained through a
no. 100 steel mesh and the cells centrifuged. The resuspended
pellet was strained again through a 50-micron nylon sieve to re-
move any remaining clumps. The cells were then counted and
total leukocyte numbers determined for each mouse. Next,
cytospin slides were prepared, fixed, Wright stained, and the per-
centages of leukocyte populations were determined by standard
200-cell differential analysis. For flow cytometry, cells were then
washed three times by centrifugation then resuspended in buf-
fered saline with 2% FBS (16).
 
Cytokines, Abs, and Cytokine Assays.
 
All cytokines and
chemokines used in this study were obtained as purified carrier-
free recombinant proteins from PeproTech and R&D Systems.
Recombinant cytokines used for T cell culture were: mouse IL-4
(DNAX) and mouse IL-12 (BD PharMingen). Monoclonal anti-
cytokine Abs used in culture were anti–IL-4 (clone 11B11; refer-
ence 17) and anti–IFN-
 
g
 
 (18). Anti–mouse CD3 and CD28 mAbs
used for T cell stimulation were purchased from BD PharMingen.
Interleukins 2, 4, 5, and 13, and IFN-
 
g 
 
were measured by stan-
dard ELISA using commercially available reagents (R&D Systems
and BD PharMingen); sensitivities ranged from 15 to 50 pg/ml.
 
Morphometry.
 
At designated intervals after tail vein challenges,
lungs and draining lymph nodes were excised and prepared as de- 
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scribed below. In some experiments, lungs were inflated and fixed
with 10% buffered formalin for morphometric analysis. Granu-
loma area was measured in a blinded fashion in hematoxylin and
eosin–stained sections of paraffin-embedded lungs using a mor-
phometer and software program (The Morphometer). A mini-
mum of 20 lesions was measured per lung. Only granulomas with
full cross-sections of the bead nidus were measured.
 
Differential Analyses of Granulomas, Blood, and Bone Marrow.
 
Dispersed granulomas were prepared as described previously (19).
A 200-cell differential analysis was performed on duplicate
Wright-stained cytospin preparations of dispersed granulomas. At
the time of sacrifice, samples of blood were obtained for total leu-
kocyte counting and 100-cell differential. Bone marrow was ob-
tained by perfusion of the femur, and then cytospin preparations
were subjected to 200-cell differential.
 
Lymph Node Cell Culture.
 
Mediastinal lymph nodes were col-
lected aseptically at the time of lung harvest and teased into a sin-
gle cell suspension. After washing, the cells were cultured in
RPMI 1640 medium (JRH Biosciences) containing 10% FBS
(Intergen), 10 mM glutamine, and 100 mg/ml streptomycin, and
100 U/ml penicillin (RPMI-FBS) at 5 
 
3 
 
10
 
6
 
 cells/ml in 100-mm
dishes with 5 
 
m
 
g/ml PPD or SEA for 24 h at 37
 
8
 
C in a humidi-
fied 5% CO
 
2
 
 atmosphere. Supernates were collected by centrifu-
gation and stored at 
 
2
 
45
 
8
 
C before performing cytokine assays.
 
Eosinophil Assays.
 
Eosinophils were obtained from either the
spleen or blood of transgenic mice expressing the IL-5 gene in
multiple tissues (unpublished observations). After lysing red blood
cells in lysis buffer (Sigma-Aldrich), cells were spun and the pellets
resuspended in RPMI supplemented with 10% FCS and 50 
 
m
 
M
 
b
 
-mercaptoethanol. Cells were cultured for 5 d and used for RNA
and calcium flux experiments. Before RNA extraction, flow cy-
tometry and hematoxylin/eosin staining was used to determine vi-
ability and cellular composition. Over 90% of the cells in culture
were alive, had typical cytoplasmic eosinophilic granules, and were
CCR3/Mac-1 positive. RNA was extracted by conventional
methods from the thymus of both CCR8
 
1
 
/
 
1
 
 and CCR8
 
2
 
/
 
2
 
 mice
(as control for CCR8 reaction) and from the cultured eosinophils
using methods described below. cDNA was synthesized using Su-
perScript Preamplification System (GIBCO BRL) according to the
manufacturer’s recommendations. PCR reactions were done using
the following primers for CCR8: TY248, 5
 
9
 
-ATGACCGAC-
TACTACCCTGATTTCT-3
 
9
 
, and TY249, 5
 
9
 
-ACGCTGGC-
CGTCCTCACCTTGATGG-3
 
9
 
; for CCR3: TY254, 5
 
9
 
-
AGACTGTGGTTGAAAGCTTTGAGAC-3
 
9
 
, and TY255, 5
 
9
 
-
TTGTAGCTTCCTGTACTTTATGAGG-3
 
9
 
; for G3PDH:
5
 
9
 
-TGAAGGTCGGTGTGAACGGATTTGGC-3
 
9
 
 and 5
 
9
 
-
CATGTAAGGCCATGAGGTCCACCAC-3
 
9.
The PCR conditions were: 948C for 2 min, then 35 cycles of
948C for 3 min, 558C for 1 min, 728C for 1 min, and 728C for 5
min. The final PCR products were analyzed on a 2% agarose gel
containing ethidium bromide. Intracellular calcium mobilization
was examined in real time using fluorescence imaging plate reader
(FLIPR; Molecular Devices). Eosinophils were loaded with Fluo-
3-AM (Sigma-Aldrich) in RPMI containing 10% serum for 1 h at
378C, then washed three times in flux buffer (HBSS, 20 mM
Hepes, 0.1% BSA). Just before analysis, cells were aliquoted into
polylysine-coated 96-well black-walled plates at a density of 5 3
105 cells/well and spun for 2 min at 300 g to settle cells. The data
obtained were expressed as fluorescence units versus time.
Chemokines were obtained from R&D Systems.
Lung RNA Extraction. Perfused lung lobes excluding major
bronchi were snap frozen with liquid nitrogen and total cellular
RNA was extracted by a modified method of Chirgwin et al. (20)
and Jonas et al. (21). The frozen tissues were suspended in extrac-
tion buffer (25 mM Tris, pH 8.0, 4.2 M guanidine isothiocyan-
ate, 0.5% Sarkosyl, and 0.1 M 2-mercaptoethanol), homogenized,
then added to an equal volume of extraction buffer (100 mM
Tris, pH 8.0, 10 mM EDTA, and 1% SDS). The mixture was
then serially extracted with chloroform-phenol and chloroform-
isoamyl alcohol. The RNA is next precipitated at 2708C in ethyl
alcohol, washed, and reprecipitated. The pellet was finally dis-
solved in DEPC water and RNA concentrations determined
spectrophotometrically before storage at 2708C.
Cytokine Primers and Probes. Cytokine primers and probes
(18–22 mer) were designed based on mRNA nucleotide se-
quences downloaded from the National Center for Biotechnol-
ogy Information (NCBI) database and using primer design soft-
ware (Premier Biosoft International). Designed primer and probe
sequences for murine IFN-g, IL-4, IL-5, IL-13, and endoplasmic
reticulum–specific cyclophilin mRNA have been published pre-
viously (13). All primers and biotinylated probes were prepared
by Genosys Biotechnologies Inc.
RT-PCR ELISA Detection of Cytokine mRNA. The isolated
RNA was reverse transcribed to DNA and detection of PCR
products was performed by semiquantitative colorimetric PCR-
ELISA as described previously (13, 22). A 96-well plate ELISA
reader was used to measure OD at 405 nm at 15 and 30 min. The
mRNA ratio was calculated as follows: mRNA ratio 5 OD target
gene/OD housekeeping gene (cyclophilin). Unlike simple gel de-
tection, the PCR-ELISA method employs a hybridization step that
specifically captures target amplicons. Consequently, it is highly
specific and has proven to be 10–100-fold more sensitive than gel
detection and allows amplification cycles to be kept to a minimum.
Th Cell Development In Vitro. Naive CD41 T cells were pre-
pared as described previously (23). Cultures were established by
stimulating cells with anti-CD3 and anti-CD28 in 24-well plates
coated with anti-CD3 in PBS (10 mg/ml, 0.5 ml per well) for at
least 2 h at 378C in a humidified incubator pulsed with CO2, and
wells were washed twice with cRPMI before use; soluble anti-
CD28 was added to the cultures at 10 mg/ml and cultures were at
106 cells/well, in the presence of medium alone, IL-4 (10 ng/ml)
plus anti–IFN-g mAb (10 mg/ml; Th2 conditions), or IL-12 (5
ng/ml) plus anti–IL-4 (10 mg/ml; Th1 conditions). After 3 d,
cultures were split 1:3, and placed in fresh wells. After 6 d, T cells
were harvested, counted, and restimulated for phenotype analysis.
The method for the intracellular cytokine staining was as reported
(24). In brief, T cells were stimulated with PMA (50 ng/ml) and
ionomycin (500 ng/ml) at 106 cells/ml in 24-well plates, after 2 h
brefeldin A (10 ng/ml) was added, and 2 h later the cells were
harvested and fixed. Cells were permeabilized with 0.5% saponin
and stained with anti–IFN-g–FITC, anti–IL-4–PE, or isotype
controls as described (24). The cells were analyzed using a FAC-
Scan™ flow cytometer (Becton Dickinson).
Statistics. The paired Student’s t test was used to compare
paired groups. Analysis of variance (ANOVA) was used for multi-
group analysis. Values of P . 0.05 were considered to indicate
lack of significance.
Results
CCR82/2 Mice Develop and Reproduce Normally. Mice
lacking CCR8 (Fig. 1) developed normally to term and
were fertile. Histologic and flow cytometric analysis of lym-
phoid and hematopoietic organs, including thymus, lymph
nodes, spleen, blood, and bone marrow, did not reveal sig-576 Impaired Th2 Responses in CCR8 Knockout Mice
nificant developmental differences between CCR82/2 and
control mice (not shown). The mutant animals had a nor-
mal life span and did not spontaneously develop disease.
CCR8 Deletion Impairs Local Th2 but Not Th1 Cytokine
Responses. Anamnestic Th1 and Th2 responses can be
studied in mice by sensitizing with protein Ags of M. bovis
(PPD) or S. mansoni eggs (SEA) followed by an intravenous
challenge of agarose beads covalently coupled to the re-
spective sensitizing antigens. In these models, the antigen-
coated beads embolize to the lung where they induce gran-
ulomatous responses that are maximal at day 4 (13, 19). To
directly compare the effect of the CCR8 deletion on de-
fined Th1 and Th2 memory responses, groups of CCR81/1
and CCR82/2 mice were sensitized with either M. bovis
PPD in CFA or S. mansoni eggs. 2 wk after sensitization,
lung granulomas were elicited in the respective groups by
embolization of agarose beads covalently coupled to PPD
or SEA (4 ng/bead). Multiple parameters were then as-
sessed on day 4, the time of maximum lung granuloma for-
mation.
Fig. 2, top left shows the effect of CCR8 deletion on
day 4, type 1 (PPD), and type 2 (SEA) granuloma forma-
tion. Interestingly, CCR8 deletion had no significant effect
on either type 1 or type 2 lesion cross sectional area. How-
ever, although type 1 lesions were histologically un-
changed, the normally eosinophil-rich, type 2 lesions
showed an apparent reduction in eosinophil content (Fig.
2, bottom). Quantitative analysis after enzymatic dispersal
of lesions confirmed a significant abrogation of eosinophils
(decreasing by 25 to 50% in three separate experiments). In
contrast, type 1 lesion composition was unaffected by
CCR8 deficiency (Fig. 2, top right).
To assess the effect of CCR8 deletion on cytokine pro-
files in the local inflammatory environment, we measured
cytokine mRNA and protein levels in lungs with type 1
Figure 1. Generation of CCR8
knockout mice. (A) CCR8 targeting
vector; (B) CCR8 genomic locus; (C)
predicted recombined CCR8 locus;
and (D) RT-PCR demonstration  of
disrupted CCR8 transcription in
CCR82/2 mice. Messenger RNA was
isolated from lungs of five mice with
type 2 SEA granuloma formation and
subjected to semiquantitative RT-PCR. No CCR8 mRNA was detected
in knockout mice. *P , 0.05 comparing CCR81/1 to CCR82/2.
Figure 2. Effect of CCR8 deletion on secondary type
1 (PPD) and type 2 (SEA) granuloma formation. Groups
of CCR81/1 (129 3 B6) and CCR82/2 (129 3 B6)
mice were sensitized subcutaneously with M. bovis PPD
in Freund’s adjuvant or intraperitoneally with 3,000 S.
mansoni eggs. After 14 d of sensitization, lung granulomas
were elicited with 6,000 PPD or SEA Ag-coated beads.
Granulomas were examined on day 4 after bead chal-
lenge. (Top left) Type 1 and type 2 granuloma cross-sec-
tional areas. (Top right) Cellular composition of type 1
and type 2 lung granulomas. Five to six mice per group.
(Bottom) Histologic appearances of type 2 (SEA) bead
granulomas in CCR81/1 and CCR82/2 (original magni-
fications: 3400; inset, 3800). All observations were re-
peated in three separate experiments. Bars are means 6
SEM. *P , 0.05 comparing CCR81/1 to CCR82/2.
Findings were similar in separate studies using either
129sv or 129sv 3 C57BL/6 F2 background mice. Lym,
lymphocytes; Mac, macrophages; Eos, eosinophils; Neu,
neutrophils.577 Chensue et al.
and type 2 granulomas. IFN-g, IL-4, IL-5, and IL-13 tran-
scripts were analyzed by RT-PCR ELISA. As shown in
Fig. 3 A, cytokine transcript levels were not significantly af-
fected by CCR8 deficiency during the type 1 response,
which was characterized by a predominant increase in
IFN-g message compared with unchallenged lungs. In
contrast, the type 2 responses were markedly reduced in
the lungs of CCR82/2 mice. In particular, levels of IL-5
and IL-13 mRNA were reduced by z30 and 40%, respec-
tively (Fig. 3 B). In some experiments, the levels of IL-13
transcripts were similar to those expressed in unchallenged
lungs. Despite reductions in IL-5 and IL-13 mRNA, IL-4
transcript levels were unchanged and interestingly, IFN-g
transcripts were increased two- to threefold. It should be
noted that transcripts for CCR8 were detected in lungs of
CCR81/1 mice with both type 1 and type 2 inflammation,
but as expected these were absent in CCR82/2 mice (Fig.
1 D).
Cytokine transcript levels correlated well with direct
measurement of cytokine protein levels in lung extracts.
These likewise showed an unchanged type 1 pattern (Fig. 3
C). However, the type 2 pattern showed significant reduc-
tions in IL-5 and IL-13 (ranging from 30 to 80% in separate
experiments), but there was no detectable change in IL-4
(Fig. 3 D). Levels of IFN-g protein were unchanged de-
spite the observed increase in message.
CCR8 Deletion Impairs Th2 but Not Th1 Cytokine Re-
sponses in Regional Lymphoid Tissue. To determine if the
Th2 cytokine defect extended to lymphoid tissue, draining
mediastinal lymph nodes were cultured and analyzed for
cytokine profiles. Both type 1 and type 2 Ag-stimulated
cultures from CCR82/2 mice displayed altered cytokine
profiles as measured by protein ELISA. The IFN-g pro-
duction by type 1 cultures was augmented by nearly three-
fold in CCR82/2 mice and the low levels of IL-5 and IL-
13 produced were reduced even further (Fig. 4, top). In
type 2 node cultures, IL-5 decreased by 35 to 45% and IL-
13 by 30 to 80% in three separate experiments. In addition,
the normally low IFN-g levels in type 2 cultures increased
by 2- to 10-fold (Fig. 4, bottom). Interestingly, there was
no consistent effect on IL-4, which was significantly re-
duced in two experiments and unchanged in two others.
In summary, both local and regional cytokine analyses
indicated impaired IL-5 and IL-13 production in CCR82/2
mice during the type 2 response with no impairment or
augmentation of type 1 cytokines.
Eosinophil Accumulation Is Attenuated in CCR82/2 Allergic
Mice. We next examined the effect of CCR8 deletion in
mouse models of allergic airway inflammation. In a well-
characterized model of aerosolized ovalbumin-induced, al-
lergic pulmonary inflammation (15), antigen-challenged
CCR82/2 mice had fewer peribronchial eosinophils than
challenged CCR81/1 mice, as demonstrated by histologic
examination (Fig. 5 A). Analysis of the bronchoalveolar la-
vage (BAL) of challenged lungs likewise revealed a signifi-
cant decrease in eosinophils in the CCR82/2 mice (Fig. 5
B). These results indicate that CCR82/2 mice have re-
duced pulmonary eosinophil accumulation after sensitiza-
tion and inhalation of aerosolized ovalbumin.
To determine whether the impaired eosinophil recruit-
ment in lungs of ovalbumin-challenged CCR82/2 mice
was similarly impaired in another model of allergic pulmo-
nary inflammation, we performed experiments using cock-
roach antigen (CRA). In humans, particularly in inner city
children, allergic responses to CRAs are recognized as a
Figure 3. Effect of CCR8 deletion on cytokine mRNA and protein
levels in lungs with secondary type 1 (PPD) and type 2 (SEA) granuloma
formation. Lung granulomas were induced in CCR81/1(129 3 B6) and
CCR82/2(129 3 B6), as described in Materials and Methods, then on
day 4 upper and lower right lung lobes were snap frozen for parallel
mRNA and protein analysis. Relative transcript levels were measured by
RT-PCR-ELISA. Cytokine levels were determined by ELISA in aque-
ous extracts then normalized to total protein. Lungs of untreated mice
served as baseline controls. Untreated CCR81/1 and CCR82/2 controls
were statistically equivalent. CCR81/1 (black bars); CCR82/2 (shaded
bars); untreated mice (white bars). (A and B) Cytokine mRNA ratios of
type 1 and type 2 lungs, respectively; (C and D) corresponding cytokine
protein levels. Values are means 6 SEM derived from the lungs of five to
six mice. *P  , 0.05 comparing CCR81/1 to CCR82/2 lungs by
ANOVA. Findings were similar in separate studies using either 129sv or
129sv 3 C57BL/6 F2 background mice.
Figure 4. Effect of CCR8 de-
letion on cytokine profiles in
draining lymph nodes cultures
during secondary type 1 (PPD)
and type 2 (SEA) granuloma for-
mation. Lung granulomas were
induced in CCR81/1  (129  3
B6) and CCR82/2 (129 3 B6),
as described in Materials and
Methods, then on day 4 draining
lymph nodes were collected and
cultured. Bars are means 6 SEM
of Ag-elicited cytokine levels
from a representative experi-
ment. (Top) Type 1 (PPD) re-
sponse; (bottom) type 2 (SEA)
response. Five to six animals per
group. All observations were re-
peated in three separate experi-
ments and findings were similar using either 129sv or 129sv 3 C57BL/6
F2 background mice. *P , 0.05 comparing CCR81/1 to CCR82/2.578 Impaired Th2 Responses in CCR8 Knockout Mice
major cause of asthma. The murine model of CRA-
induced allergic airway inflammation recapitulates many
aspects of human asthma and is considered a more clinically
relevant experimental model of asthma (14). After CRA
sensitization and challenge, CCR81/1 and CCR82/2 mice
were assessed histologically for eosinophil accumulation
within the lungs. As in the ovalbumin model, CCR82/2
mice had markedly fewer peribronchial eosinophils com-
pared with CCR81/1 mice (Fig. 6 A). Morphometric enu-
meration of the peribronchial eosinophils revealed that
challenged CCR82/2 mice had a 70% decrease compared
with CCR81/1 mice (Fig. 6 B). However, a defect of lym-
phocyte recruitment could not be established. As shown in
Table I, flow cytometric analysis of enzymatically dispersed
lungs did not reveal significant differences between the two
groups in absolute numbers of CD41 and CD81 T cells.
This finding indicated that CCR8 deficiency did not affect
gross lymphocyte infiltration, yet effects on minor popula-
tions of antigen-specific cells cannot be ruled out. Simi-
larly, no defects in macrophage mobilization could be es-
tablished. In fact, by flow cytometry the proportion of cells
bearing the monocyte/macrophage marker, F4/80, was in-
creased (CCR81/1, 25 6 5% versus CCR82/2, 46 6 5%;
n 5 4 per group). The latter was largely a relative change,
because in ovalbumin-challenged mice, CRA-challenged
CCR82/2 mice had an z50% reduction in the number of
Figure 5. Reduced eosinophil accumulation in CCR82/2
mice in ovalbumin allergic airway inflammation. (A) Histo-
logic appearance of peribronchial eosinophil accumulation
in lungs from ovalbumin sensitized and rechallenged
CCR81/1 (129  3 B6) and CCR82/2 (129  3 B6) mice
(original magnification: 3400); (B) direct quantitation of
eosinophils in BAL fluid. Bars represent means 6 SEM.
*P , 0.05 compared with sensitized control 1/1 mice.
Findings were similar in separate studies using either 129sv
or 129sv 3 C57BL/6 F2 background mice.
Figure 6. Reduced peribronchial eosinophil accumula-
tion in cockroach allergen–sensitized CCR82/2 mice. (A)
Histologic appearance of peribronchial eosinophil accumu-
lation in lungs from CRA-sensitized and rechallenged
CCR81/1 and CCR82/2 mice; (B) morphometric enumer-
ation of peribronchial eosinophils in CCR81/1 and
CCR82/2 mice; (C) parallel analysis of EPO in the BAL
fluid of the CCR81/1 (129sv) and CCR82/2 (129sv) mice. Bars represent the means 6 SEM of five mice. *P , 0.05. Findings were similar in separate
studies using either 129sv or 129sv 3 C57BL/6 F2 background mice. HPF, high power field.579 Chensue et al.
eosinophils in the lung compared with CCR81/1 mice
(data not shown). This was further demonstrated in the
CRA model by quantitative analysis of eosinophil activity
in the BAL using another parameter, eosinophil peroxidase
(EPO) levels, which revealed that CCR82/2 mice had a
75% reduction of EPO levels in cell-free BAL compared
with CCR81/1 mice (Fig. 6 C). Thus, in two different
models of allergic pulmonary inflammation, CCR82/2
mice displayed relatively specific reduction in eosinophil
recruitment in and around the airways compared with sim-
ilarly challenged CCR81/1 mice.
To investigate the underlying causes of the reduced eo-
sinophil recruitment in allergen-challenged CCR82/2 mice,
we conducted a more detailed series of experiments using
the CRA model. First, blood collected from unchallenged
CCR81/1 and CCR82/2 mice was differentially stained
for leukocytes. Before allergen challenge there was no dif-
ference between the groups in the number of circulating
eosinophils. However, after antigen sensitization and re-
challenge, a significant reduction was observed in the num-
ber of eosinophils in the blood of CCR82/2 mice com-
pared with CCR81/1 mice; eosinophils averaged 10.3 6
3.7% of the circulating cells in the CCR81/1 group and
,2% in the CCR82/2 mice. These results suggest that the
reduction in the numbers of eosinophils in the lungs might
be related to a defect in eosinophil maturation or release
into the circulation.
Th2 Type Cytokines Are Reduced in Lungs of CCR82/2
Allergic Mice. Next, we assessed cytokine levels in whole
lung homogenates at different time points during the
CRA-induced allergic response. Levels of IFN-g and IL-
12 were not altered within the CCR82/2 lungs compared
with CCR81/1 lungs (data not shown). However, the lev-
els of IL-4 (Fig. 7 A), IL-5 (Fig. 7 C), and IL-13 (Fig. 7 D)
were significantly reduced in the CCR82/2 lungs. Thus,
unlike the type 2 granuloma model, reduced IL-4 levels
were demonstrable in the allergy model possibly due to the
greater cellular complexity of the granulomatous response.
It should be noted that despite reductions in cytokines, no
consistent changes were observed in airway hyperreactivity
(data not shown), supporting the notion that airway hyper-
reactivity can be established independently of IL-4 (25).
Circulating Eosinophils Do Not Express CCR8 or Respond
to CCR8 Ligands. A potential explanation for the re-
duced eosinophil recruitment in CCR82/2 mice was that
eosinophils use CCR8 for chemotaxis. To address this
question, we examined CCR8 expression and functional
responses (calcium flux and chemotaxis) in eosinophils
from CCR81/1 mice. Although expression of CCR3 was
readily detected by RT-PCR analysis (Fig. 8 A), no CCR8
mRNA was detected in these cells. These findings were
confirmed by functional assays examining calcium flux in
response to CCR3 and CCR8 ligands. As expected, both
human and mouse eotaxin generated a significant calcium
flux (Fig. 8 B) in mouse eosinophils, whereas no such re-
sponse was observed with either TCA3 or its human ho-
mologue I-309. In vitro chemotaxis assays gave comparable
results. The results of all assays were similar regardless of
whether the eosinophils were isolated from blood or spleen
(data not shown). These results indicate that CCR8 is not
expressed by peripheral mouse eosinophils.
Eosinophil Production Is Impaired in CCR82/2 Mice. As
CCR8 was not normally expressed by peripheral eosino-
phils, then impaired recruitment during the type 2 response
was likely due to other factors. Circulating IL-5 is an im-
portant mediator for eosinophil recruitment, function, and
the differentiation in bone marrow (26–28). Moreover, it is
specifically required for eosinophil mobilization to schisto-
some egg granulomas (29). To determine if impaired eosin-
ophil recruitment was possibly related to a reduction of
systemic IL-5 release, we examined peripheral blood leu-
kocytes, bone marrow eosinophilopoiesis, and serum IL-5
levels in mice with ongoing type 1 and type 2 granuloma
formation. Differential analysis revealed no change in blood
leukocyte populations during the type 1 response (data not
shown). In contrast, distinct changes were observed in
Table I. Analysis of Lymphocyte Subsets in Cockroach
Allergen-challenged Lungs of Control and CCR82/2 Mice
Group
Total cells
(107)
CD41
(106)
CD81
(106)
CD191
(106)
CCR81/1 2.2 6 0.16 1.2 6 0.8 0.50 6 0.2 0.8 6 0.2
CCR82/2 1.6 6 0.18 1.8 6 0.14 0.58 6 0.3 1.3 6 0.14
P 0.015 .0.05 .0.05 .0.05
Cockroach antigen sensitization and challenge was performed as
described in Materials and Methods. Lungs were collected and dispersed
24 h after the final intratracheal challenge, and then subjected to flow
cytometric analysis. Values are means 6 SD derived from four
individual mice. The reduction in total cell numbers in CCR82/2 was
due to decreased eosinophil recruitment (CCR81/1, 25.5 6 5% versus
CCR82/2, 14 6 4%). Control and knockout mice were on inbred 129
background.
Figure 7. Reduced cytokine
levels in the lungs of cockroach
allergen challenged CCR82/2
mice. Aqueous extracts were
prepared from whole snap frozen
lungs of allergen-challenged
CCR81/1 (129sv) and CCR82/2
(129sv) mice at 6 h after chal-
lenge, then assayed for cytokines
with values expressed as amount
per whole lung. (A) IL-4 levels;
(B) IL-5 levels; and (C) IL-13
levels. Bars represent the mean 6
SEM of individual lungs of four
mice. *P , 0.05. Findings were
similar in separate studies using
either 129sv or 129sv 3 C57BL/6
F2 background mice.580 Impaired Th2 Responses in CCR8 Knockout Mice
CCR82/2 mice with type 2 granulomas. As shown in Fig.
9, the type 2 response was associated with eosinophil mobi-
lization in blood and bone marrow, and as observed in the
CRA allergy model, knockout mice displayed an z70%
decrease in absolute numbers of circulating eosinophils
(Fig. 9 A), suggesting a systemic impairment in eosinophil
production. Indeed, CCR82/2 mice with type 2 lesions
showed reduced eosinophil differentiation in bone marrow
with the ratio of eosinophil to neutrophil differentiation
decreasing by 50% (Fig. 9). In addition, the eosino-
philopoietic cytokine, IL-5, was similarly reduced in serum
(Fig. 9 C), suggesting that impaired eosinophil mobilization
could be related to a systemic defect in IL-5 production.
CCR8 Is Not Required for In Vitro Development of Th2
Cells. A possible cause for the impaired Th2 cytokine re-
sponse in CCR82/2 mice was that CCR8 was required for
the normal development and expansion of Th2 cells. To
test this possibility, naive CD41 T cells from wild-type or
CCR8-deficient mice were cultured with anti-CD3 and
anti-CD28 under Th1 (IL-12, anti–IL-4), neutral (no cy-
tokine additions), and Th2 (IL-4, anti–IL-12) conditions.
After 6 d, the T cells were harvested and restimulated at
equal cell number with PMA and ionomycin and their cy-
tokine profile was analyzed using flow cytometric analysis
for intracellular cytokine production. As shown in Fig. 10,
T cells cultured under Th1 conditions produced IFN-g and
IL-10 and no IL-4 or IL-5, as described previously (30).
However, there was no difference in the number of IFN-
g1 or IFN-g1IL-101-producing Th1 cells obtained from
the wild-type (18%) and CCR8 (17%) mice. In addition, T
cells cultured under Th2 conditions differentiated into cells
producing IL-4, IL-5, and IL-10, but no IFN-g, as de-
scribed previously (30–33). Again, similar numbers of T
cells produced IL-4, IL-5, and IL-10 when they were cul-
tured from wild-type (20% IL-41, 17% IL-51, and 52% IL-
101) or CCR82/2 (25% IL-41, 23% IL-51, and 46% IL-
101) mice. T cells cultured under neutral conditions differ-
entiated into Th2-type cells reflecting endogenous levels of
IL-4 during primary culture, which can differ depending on
the genetic background of the mouse as well as the number
of CD41 T cells per well (30). Again there was no signifi-
cant difference in the number of IL-4–, IL-5–, or IL-10–
producing cells obtained using CD41 T cells from wild-
type (48% IL-41, 16% IL-51, and 49% IL-101) or CCR82/2
(50% IL-41, 23% IL-51, and 34% IL-101). Low levels of
IFN-g were observed under these conditions but were no
different in wild-type versus CCR82/2 mice. These data
clearly show that although CCR8 is expressed on Th2 but
not Th1 cells (11), it has no significant effect on the ability
of naive CD41 T cells to differentiate into Th2 or Th1
cells. Of significance is the lack of difference in IL-4– or IL-
5–producing cells obtained under the more limiting neutral
conditions. It remains possible that this effect may only be
observed under more limiting conditions of antigen dose.
Discussion
Human and murine CCR8 are homologous G protein–
coupled receptors whose reported ligands include human
Figure 8. Circulating eosinophils lack CCR8 mRNA and are unre-
sponsive to CCR8 ligands. (A) Eosinophils isolated from the blood of IL-5
transgenic mice were examined for expression of CCR3 and CCR8 by
RT-PCR. CCR3 (184-bp band) expression was detected in mouse eosin-
ophils (2 3 105 cells). CCR8 expression was not detected in circulating
eosinophils. CCR8 transcript (411-bp band) was detected in wild-type
thymocytes, but not in thymocytes from CCR82/2 mice (negative con-
trol). GAPDH (540-bp band) was included as a procedural control. (B)
Eosinophils (blood) were also examined for their ability to flux calcium in
response to CCR3 and CCR8 ligands. Human and mouse eotaxin (100
ng/ml) both generated a significant transient calcium flux, whereas TCA3
and I-309 (100 ng/ml, respectively) were ineffective in this assay.
Figure 9. Blood and bone
marrow eosinophil mobilization
as related to serum IL-5 levels in
CCR81/1 and CCR82/2 mice
with secondary type 2 (SEA)
granulomas. Lung granulomas
were induced in CCR81/1 and
CCR82/2 as described in Mate-
rials and Methods, then on day
4, blood, bone marrow, and se-
rum was evaluated. (A) Periph-
eral blood eosinophil counts; (B)
bone marrow eosinophil differ-
entiation index; (C) serum IL-5
levels. CCR81/1 (129 3 B6;
black bars); CCR82/2 (1293B6;
shaded bars); untreated mice
(white bars). Untreated CCR81/1
and CCR82/2 controls were sta-
tistically equivalent. *P  , 0.05
comparing sensitized CCR81/1
by ANOVA. Findings were sim-
ilar in separate studies using ei-
ther 129sv or 129sv 3 C57BL/6
F2 background mice.581 Chensue et al.
I-309, thymus and activation-regulated chemokine
(TARC), macrophage inflammatory protein (MIP)-1b,
TCA3, and liver-expressed chemokine (LEC; references
34–37). In addition, the virally encoded chemokines,
vMIP-I and vMIP-II, can also bind CCR8 (38–40). The
selective expression of CCR8 in Th2 T cells (11, 12) sug-
gests that it may have an important role in the function of
these cells. However, there are currently no experimental
data demonstrating such a role. To investigate this possibil-
ity, and to study other potential functions of CCR8, we
have generated and analyzed CCR8-deficient mice. Using
models of Th2 (schistosomal) cell-mediated immune re-
sponses as well as two models of Th2-mediated allergic air-
way disease, we show impairment of Th2 type cytokine ex-
pression and eosinophil mobilization in CCR82/2 mice.
This defect was specific to the in vivo Th2 type response, as
the Th1 response to mycobacterial Ags was not impaired by
CCR8 deficiency. Although Th2 responses were reduced
in CCR8-deficient mice in vivo compared with wild-type
mice, there was no significant difference in the ability of
naive CD41 T cells to differentiate into Th2 or Th1 cells.
In addition, functional CCR8 expression was not detected
in eosinophils, as these cells did not signal in response to the
CCR8 ligands, TCA3 and I-309. In separate studies, using
TNF or IL-4 stimulation of eosinophils, we have observed
CCR8 mRNA expression by RT-PCR, but minimal
chemotactic responses to CCR8 compared with CCR3
ligands (unpublished observations). Thus, reduced eosino-
phil mobilization seen in SEA-challenged CCR82/2 mice
was not likely due to the absence of CCR8 on eosinophils.
Rather, the observed defects in the CCR82/2 mice seemed
more related to reduced Th2 cytokines indicating the
CCR8 was important for normal Th2 cell function.
Several potential aspects of Th2 cell function may be im-
paired by CCR8 deficiency, including cell trafficking, reg-
ulation of T cell survival, and stimulation of cytokine pro-
duction. Given the well-established role of chemokines in
leukocyte trafficking, the most straightforward explanation
for our observations would be failure of Th2 cells to effi-
ciently migrate to lungs and lymph nodes and, indeed, the
observed local impairment of Th2 cytokine production in
these sites would support this notion. In addition, in vitro–
generated CCR82/2 Th2 fail to show chemotactic re-
sponses to the CCR8 ligand TCA3 (data not shown). Al-
though CCR8 likely does not contribute to trafficking of
naive T cells or Th1 cells, it may have a central role in the
trafficking of activated Th2 cells to sites of inflammation
(11, 12). Direct counts of total CD41 T cells in lungs of al-
lergen-challenged CCR82/2 mice did not reveal any gross
evidence of a recruitment defect. However, ongoing stud-
ies in our laboratory indicate that the relevant Ag-specific,
cytokine producing population represents 1% or less of the
CD41 cells. Therefore, gross CD41 counting is likely not a
sensitive parameter. Rather direct testing of migration in
vivo will be required using labeled CCR82/2 Th2 cells or
CCR82/2 mice with transgenic TCR expression.
Our results indicate a postdevelopmental functional im-
pairment of Th2 cells in CCR82/2 mice, possibly a migra-
tion defect as noted above. However, alternative sites of
compromise that could be considered include T cell activa-
tion or survival. For example, one explanation for the re-
duced Th2 cytokine production in SEA-induced granulo-
mas and draining lymph node cultures of the CCR82/2
mice is that CCR8 ligands regulate Th2 cytokine produc-
tion, either directly as costimulants, or indirectly by in-
creasing Th2 cell survival. With regard to the latter, it has
been reported that the CCR8 ligand, TCA3, a known
product of T cells (41), can inhibit apoptosis of lymphoma
cells (42). Thus, binding of TCA3 to CCR8 might protect
Th2 cells from apoptosis and thereby allow prolonged sur-
vival of Th2 populations. However, our findings that
CCR82/2 Th2 cells develop normally in vitro and that
CCR82/2 mice harbor normal numbers of Ag-specific Th2
cells in lymphoid tissue (unpublished observations) would
argue against this possibility. Other indirect T cell–related
mechanisms might include impaired CCR8-mediated mi-
gration of Ag-presenting dendritic cells or macrophages to
lymphoid tissues where accessory cells may be required for
optimal Th2 cell function. However, activation require-
ments for memory T cells are reportedly less stringent than
for naive T cells (43), and abundant potential accessory cells
are present in granulomas. Alternatively, CCR8 ligands
might directly stimulate Th2-type cytokine secretion at
critical stages of activation. This notion would be in accord
Figure 10. CCR8 is not re-
quired for in vitro development
of Th2 cells. Naive CD41 T
cells from CCR81/1 (129sv) or
CCR82/2 (129sv) mice were
stimulated with anti-CD3 and
anti-CD28 mAbs, in the pres-
ence of medium alone (neutral
conditions), IL-12 plus anti–IL-4
mAbs (Th1 conditions), or IL-4
plus anti–IFN-g mAbs (Th2
conditions), and then harvested
after 6 d and restimulated for
analysis of intracellular cytokine
production by flow cytometry
(IL-4, IL-5, and IFN-g).582 Impaired Th2 Responses in CCR8 Knockout Mice
with a growing body of evidence indicating that chemo-
kines can regulate T cell maturation and function (44, 45).
In this regard, several chemokine receptors, such as CCR3,
CCR4, and CCR8 can potentially contribute to Th2 mi-
gration (11, 12, 46); therefore, it was surprising that CCR8
deletion was able to cause even a partial abrogation of the
Th2 response. Current hypothetical models suggest stage-
specific chemokine receptor expression by T cells (47);
hence, it is reasonable to envision a stepwise expression of
chemokine receptors that may govern both T cell migra-
tion and effector functions. It has recently been demon-
strated that the Th2 cell–associated chemokine receptors
CCR3 and CCR4 take dominance at different stages of
hypersensitivity responses (48), and such may be the case
with CCR8. A detailed explanation for different functional
changes transduced by chemokine receptors will require a
better understanding of the complexity of G protein–cou-
pled receptor organization and regulation.
It was observed that CCR82/2 mice displayed similar
defects in models of type 2 (SEA) bead granuloma forma-
tion and cockroach allergen challenge in all parameters ex-
cept local IL-4 production by inflamed lungs. Although the
precise explanation for this difference is unknown, it is
likely related to the different experimental conditions. Pa-
rameters were measured at 6 h after challenge in the more
acute allergy model but on day 4 in the granuloma model.
Moreover, the type 2 granuloma is a complex, chronic in-
flammatory response that involves a variety of cell types
that could serve as compensatory sources of IL-4. Among
these are lymphoid populations such as double negative
(CD42CD82) T cells, CD81 type 2 T cells, and non-T,
non-B cells (49–51).
Finally, it should be noted that CCR82/2 mice had a
phenotype similar to IL-42/2 mice under comparable ex-
perimental conditions (13). Both knockouts display re-
duced blood eosinophilia and impaired local eosinophil
recruitment that is associated with attenuation but not
elimination of Th2 cytokines. Similar to IL-4 knockout
mice, both type 1 and type 2 lymph node cultures
showed increased IFN-g production consistent with alle-
viated Th2-mediated cytokine cross-regulation. Like IL-4
knockout mice, the secondary type 2 granuloma in
CCR82/2 mice did not completely shift to a type 1 pro-
file but established a compensated Th2-like granuloma of
similar size despite reduced Th2 cytokine production.
These findings are quite unlike those we reported for
CCR22/2 mice, which have deficits in IFN-g and IL-2
production and impaired monocyte recruitment with
minor effects on Th2 cytokine production (52, 53).
Thus, CCR82/2 mice like IL-42/2 mice have likely
adapted to their deficiency, although in both mutants the
eosinophil mobilization defect could not be completely
overcome.
Taken together, our results demonstrate that CCR8
plays a role in Th2 responses in vivo and provide further
support to the concept that chemokines and their receptors
can potentially be targeted to modulate Th2-mediated im-
mune responses.
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